查看購物車
  • Simplified Chinese
  • English
  • Japanese
全球 EPA 和 DHA 市場 - 2023-2030 年
市場調查報告書
商品編碼
1316258

全球 EPA 和 DHA 市場 - 2023-2030 年

Global EPA & DHA Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

全球EPA 和DHA 市場規模在2022 年達到18 億美元，預計到2030 年將達到29 億美元，並在2023-2030 年期間以6.5% 的複合年成長率成長。 EPA 和DHA 市場正在見證產品多樣化和創新的上升趨勢。例如，一些公司正在推出基於藻類的EPA 和DHA 補充劑，以滿足人們對永續的植物性歐米伽-3 來源日益成長的需求。

由於人們越來越意識到歐米伽-3 脂肪酸對健康的益處，EPA 和DHA 市場正呈現大幅成長。 EPA（二十碳五烯酸）和DHA（二十二碳六烯酸）是支持心血管和大腦健康的重要成分。市場提供多種產品選擇，包括魚油、藻油和歐米伽-3 補充劑，方便消費者在飲食中攝入這些營養素。

富含歐米伽-3 的功能性食品的採用率不斷上升，推動了EPA 和DHA 市場的發展。食品製造商正在將EPA 和DHA 添加到各種強化食品和飲料中，以迎合注重健康的消費者的需求。例如，富含歐米伽-3 的牛奶、優格和穀類食品的供應量不斷增加。此外，人們對寵物健康和營養的日益關注也促使EPA 和DHA 被添加到寵物食品中，推動了寵物營養品市場的擴大。

市場動態

全球對Omega-3 益處和保健建議的重視推動了EPA 和DHA 市場的成長

全球衛生組織和監管機構一直在強調歐米伽-3 脂肪酸對促進公眾健康的重要性。各國政府正在實施相關政策，通過膳食指南和公共衛生運動鼓勵人們食用EPA 和DHA。此外，還制定了相關法規來確保EPA 和DHA 產品的品質和安全，從而為消費者提供標準化和可靠的補充劑。

這些支持措施增強了消費者的信心，從而推動了EPA 和DHA 的市場趨勢。此外，omega-3 補充劑被涵蓋醫療保健建議和治療方案也促進了市場成長。醫療保健專業人員擴大向有心血管問題、炎症和其他健康問題的患者推薦EPA 和DHA 補充劑，從而進一步推動了對這些必需脂肪酸的需求。

對植物來源的需求增加推動了EPA 和DHA 市場的成長

隨著人們對永續發展和環境問題的認知不斷提高，對藻油等植物性EPA 和DHA 來源的需求也在不斷成長。藻類提取的歐米伽-3 補充劑在尋求魚油替代品的素食主義者和素食消費者中越來越受歡迎。藻油提供了一種永續的環保選擇，減少了對海洋資源的壓力，減輕了捕魚對環境的影響。

隨著以植物為基礎的運動逐漸興起，對來自藻類的EPA 和DHA 補充劑的需求預計將上升，從而推動EPA 和DHA 市場的成長。預計藻類EPA 和DHA 產品的市場佔有率將隨著消費者偏好的變化和道德因素的考慮而增加。

污染物問題給EPA 和DHA 市場成長帶來挑戰

EPA 和DHA 市場的主要阻礙因素之一是魚油和海產品中污染物的潛在風險。由於這些歐米加-3 脂肪酸通常來自魚類和其他海洋生物，因此環境污染物、重金屬和毒素有可能在它們體內積累。汞、多氯聯苯和二噁英等污染物可能存在於某些魚類物種和海洋油中，從而引發消費者對產品安全和潛在健康風險的擔憂。

為解決這一制約因素，EPA 和DHA 市場的製造商和供應商需要實施嚴格的品質控制措施，如第三方檢測和認證，以確保其產品符合安全標準和法規要求。提供純化和高品質的EPA 和DHA 補充劑有助於建立消費者信任，克服市場上的這一制約因素。

COVID-19 影響分析

COVID-19 分析包括COVID 前情景、COVID 情景和COVID 後情景，以及定價動態（包括大流行期間和之後的定價變化，並與COVID 前情景進行比較）、供求光譜（由於貿易限制、封鎖和後續問題而導致的供需變化）、政府計劃（政府機構為振興市場、部門或行業而採取的計劃）和製造商戰略計劃（此處將涵蓋製造商為緩解COVID 問題而採取的措施）。

目 錄

第1 章：研究方法與範圍

  • 研究方法
  • 報告的研究目標和範圍

第2章：市場定義與概述

第3章：執行摘要

  • 按類型分類的市場摘要
  • 按來源分類的市場摘要
  • 按應用分類的市場片段
  • 按地區分類的市場摘要

第4 章：市場動態

  • 市場影響因素
    • 驅動因素
    • 限制因素
    • 機會
    • 影響分析

第5 章：行業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第6 章：COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的情況
    • COVID-19 期間的情景
    • COVID-19 之後的情況
  • COVID-19 期間的定價動態
  • 供需關係
  • 大流行期間與市場相關的政府計劃
  • 製造商的戰略計劃
  • 結論

第7 章：按類型分類

  • 二十碳五烯酸(EPA)
  • 二十二碳六烯酸(DHA)

第8 章：按來源

  • 藻油
  • 磷蝦油
  • 魚油
  • 其他

第9 章：按應用分類

  • 嬰兒配方奶粉
  • 膳食補充劑
  • 強化食品和飲料
  • 藥品
  • 其他

第10 章：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東和非洲

第11 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 合併與收購分析

第十二章：公司簡介

  • BASF SE
    • 公司概況
    • 產品組合和說明
    • 財務概況
    • 主要發展
  • Koninklijke DSM NV
  • Corbion NV
  • The Archer Daniels Midland Company
  • Croda International Plc
  • KD Pharma Group
  • Lonza Group Ltd.
  • Omega Protein Corporation
  • GC Rieber Oils AS
  • Polaris

第13 章：附錄

簡介目錄
Product Code: FB6504

Market Overview

The Global EPA & DHA Market reached US$ 1.8 billion in 2022 and is expected to reach US$ 2.9 billion by 2030 and is expected to grow with a CAGR of 6.5% during the forecast period 2023-2030. The EPA and DHA market is witnessing a rising trend in product diversification and innovation. For instance, companies are introducing algae-based EPA and DHA supplements to cater to the growing demand for sustainable and plant-based sources of omega-3s.

The EPA and DHA market is witnessing substantial growth due to the increasing awareness of the health benefits of omega-3 fatty acids. EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid) are essential components for supporting cardiovascular and brain health. The market offers various product options, including fish oil, algal oil, and omega-3 supplements, making it convenient for consumers to incorporate these nutrients into their diets.

The rising adoption of omega-3-enriched functional foods is driving the EPA and DHA markets. Food manufacturers are incorporating EPA and DHA into a wide range of fortified food and beverages to cater to health-conscious consumers. For example, there has been an increase in the availability of omega-3-enriched milk, yogurt, and cereals. Moreover, the growing focus on pet health and nutrition has led to the inclusion of EPA and DHA in pet food products, driving the market's expansion in the pet nutrition segment.

Market Dynamics

Global Emphasis on Omega-3 Benefits and Healthcare Recommendations Propel EPA & DHA Market Growth

Health organizations and regulatory bodies worldwide have been emphasizing the importance of omega-3 fatty acids in promoting public health. Governments are implementing policies to encourage the consumption of EPA and DHA through dietary guidelines and public health campaigns. Additionally, regulations are in place to ensure the quality and safety of EPA and DHA products, providing consumers with the assurance of standardized and reliable supplements.

These supportive measures have contributed to increased consumer confidence, thereby boosting the EPA and DHA market trends. Furthermore, the inclusion of omega-3 supplementation in healthcare recommendations and treatment protocols has bolstered market growth. Healthcare professionals are increasingly recommending EPA and DHA supplements to patients with cardiovascular issues, inflammatory conditions, and other health concerns, further driving the demand for these essential fatty acids.

Rising Demand for Plant-Based Sources Propels EPA & DHA Market Growth

With the increasing awareness of sustainability and environmental concerns, there is a growing demand for plant-based sources of EPA and DHA, such as algal oil. Algae-derived omega-3 supplements have gained popularity among vegan and vegetarian consumers who seek an alternative to fish oil. Algal oil offers a sustainable and eco-friendly option, reducing the pressure on marine resources and mitigating the environmental impact of fishing.

As the plant-based movement gains momentum, the demand for EPA and DHA supplements sourced from algae is expected to rise, propelling the growth of the EPA and DHA markets. The market share of algal-based EPA and DHA products is projected to increase in response to changing consumer preferences and ethical considerations.

Contaminant Concerns Pose Challenges to EPA and DHA Market Growth

One of the key restraints of the EPA and DHA market is the potential risk of contaminants in fish oil and marine-based products. As these omega-3 fatty acids are commonly sourced from fish and other marine organisms, there is a possibility of environmental pollutants, heavy metals, and toxins accumulating in their bodies. Contaminants like mercury, PCBs, and dioxins can be present in certain fish species and marine oils, raising concerns among consumers about product safety and potential health risks.

To address this restraint, manufacturers and suppliers in the EPA and DHA market need to implement rigorous quality control measures, such as third-party testing and certifications, to ensure that their products meet safety standards and regulatory requirements. Offering purified and high-quality EPA and DHA supplements can help build consumer trust and overcome this restraint in the market.

COVID-19 Impact Analysis

The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Segment Analysis

The global EPA & DHA market has been segmented by type, source, application, and region.

Dietary Supplements Dominate the EPA and DHA Market, Catering to Health-Conscious Consumers

The dietary supplements segment is holding the largest market share, around 45% of the EPA and DHA market. Dietary supplements containing EPA and DHA are widely consumed by individuals seeking to boost their omega-3 intake and improve overall health. These supplements offer a convenient and precise way to obtain the recommended daily dosage of these essential fatty acids.

Additionally, the rising awareness of the health benefits associated with EPA and DHA consumption has contributed to the growth of the dietary supplements segment. Moreover, EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid) are prominent types of omega-3 fatty acids found in marine oils, making them the key components of these dietary supplements. Marine oils, sourced from fish and algae, are rich in EPA and DHA, making them ideal for formulating high-quality supplements.

Geographical Analysis

Asia Pacific Emerges as a Growing Force in the EPA & DHA Market, Paving the Way for Expanding Market Share and Size

By region, the global EPA & DHA market is segmented into North America, South America, Europe, Asia-Pacific, Middle-east, and Africa.

The Asia-Pacific region's EPA and DHA market size is experiencing significant growth due to increasing consumer awareness of the health benefits associated with omega-3 fatty acids. Fish oil, algal oil, and omega-3 supplements have gained popularity as they are known to support cardiovascular health and brain function. The rising prevalence of chronic diseases has driven the demand for EPA and DHA products in this region.

As a result, companies are expanding their product offerings to cater to the diverse health needs of consumers. The EPA and DHA market share in the Asia-Pacific region is projected to witness substantial growth as more people embrace preventive healthcare measures. Additionally, the market size is expected to expand as consumers seek personalized and targeted solutions to address their specific health concerns.

Competitive Landscape

The major global players in the market include: Koninklijke DSM NV, Corbion N.V., BASF SE, The Archer Daniels Midland Company, Croda International Plc, KD Pharma Group, Lonza Group Ltd., Omega Protein Corporation, GC Rieber Oils AS, and Polaris.

Why Purchase the Report?

  • To visualize the global EPA & DHA market segmentation based on type, source, application, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities in the market by analyzing trends and co-development.
  • Excel data sheet with numerous data points of EPA & DHA market-level with all segments.
  • The PDF report consists of a cogently put-together market analysis after exhaustive qualitative interviews and an in-depth market study.
  • Product mapping is available as Excel consists of key products of all the major market players.

The global EPA & DHA market report would provide approximately 61 tables, 62 figures, and 190 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet, by Type
  • 3.2. Market Snippet, by Source
  • 3.3. Market Snippet, by Application
  • 3.4. Market Snippet, by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19 on the Market
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Eicosapentaenoic Acid (EPA)*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Docosahexaenoic Acid (DHA)

8. By Source

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 8.1.2. Market Attractiveness Index, By Source
  • 8.2. Algae Oil*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Krill oil
  • 8.4. Fish Oil
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Infant Formulae*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Dietary Supplements
  • 9.4. Fortified Food and Beverages
  • 9.5. Pharmaceuticals
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America*
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. BASF SE
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Koninklijke DSM NV
  • 12.3. Corbion N.V.
  • 12.4. The Archer Daniels Midland Company
  • 12.5. Croda International Plc
  • 12.6. KD Pharma Group
  • 12.7. Lonza Group Ltd.
  • 12.8. Omega Protein Corporation
  • 12.9. GC Rieber Oils AS
  • 12.10. Polaris

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us